What Researchers Did
Researchers retrospectively analyzed data from 100 patients treated with hyperbaric oxygen therapy (HBO) for diabetic foot ulcers (DFUs) between 2018 and 2020 to evaluate associated side effects.
What They Found
Only 6% of the 100 patients experienced side effects from hyperbaric oxygen therapy, and none of these were critical. The most frequently reported side effect was discomfort related to the confined space within the hyperbaric chamber.
What This Means for Canadian Patients
Canadian patients with diabetic foot ulcers considering hyperbaric oxygen therapy may be reassured by the low incidence of severe side effects. A multidisciplinary team approach, careful patient selection, and patient education are crucial to further minimize potential discomforts.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
As a retrospective study, it is limited by its reliance on existing data and potential for unmeasured confounding factors.